Search research articles
Contact Us
Filters
Showing results (521-530 of 836) with videos related to
Page
of 84
Sort By:
Intestinal Research
|
February 9, 2026
Correction: Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease
Shilpa Sharma
Intestinal Research
|
February 7, 2025
Elucidating the association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a focus on systemic inflammation
Sihyun Kim, Jong Pil Im
Intestinal Research
|
November 6, 2025
Comments on "Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey"
Tsutomu Nishida, Takahiro Amano, Naoto Osugi, et al.
Intestinal Research
|
June 9, 2025
Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn's disease
Robert Gilmore, Amrutha Murali, Amirah Etchegaray, et al.
Intestinal Research
|
December 25, 2025
The JAK attack: transforming the management of ulcerative colitis in India
Arshdeep Singh, Arshia Bhardwaj, Vandana Midha, et al.
Intestinal Research
|
April 25, 2025
Efficacy and safety of etrasimod in Japanese patients with ulcerative colitis: results from a phase 2 dose-ranging study
Ken Takeuchi, Hiroshi Nakase, Tadakazu Hisamatsu, et al.
Intestinal Research
|
November 18, 2025
The role of the Mediterranean diet in the management of inflammatory bowel disease: a narrative review
Peter Vivian Acire, Stephanie C Brown, Andrew S Day
Intestinal Research
|
November 6, 2025
Elderly-onset inflammatory bowel disease in Asia: clinical characteristics and therapeutic strategies
Jiyoung Yoon, Daein Kim, You Sun Kim
Intestinal Research
|
August 11, 2025
Peroxisome proliferator-activated receptors in inflammatory bowel disease: linking immunometabolism, lipid signaling, and therapeutic potential
Kiandokht Bashiri, Mark C Mattar, Alireza Meighani, et al.
Intestinal Research
|
February 18, 2016
Current status of biosimilars in the treatment of inflammatory bowel diseases
Dong Il Park
Page
of 84
Search research articles
Search
Showing results (521-530 of 836) with videos related to
Sort By:
Page
of 84
Intestinal Research
|
February 9, 2026
Correction: Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease
Shilpa Sharma
Intestinal Research
|
February 7, 2025
Elucidating the association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a focus on systemic inflammation
Sihyun Kim, Jong Pil Im
Intestinal Research
|
November 6, 2025
Comments on "Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey"
Tsutomu Nishida, Takahiro Amano, Naoto Osugi, et al.
Intestinal Research
|
June 9, 2025
Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn's disease
Robert Gilmore, Amrutha Murali, Amirah Etchegaray, et al.
Intestinal Research
|
December 25, 2025
The JAK attack: transforming the management of ulcerative colitis in India
Arshdeep Singh, Arshia Bhardwaj, Vandana Midha, et al.
Intestinal Research
|
April 25, 2025
Efficacy and safety of etrasimod in Japanese patients with ulcerative colitis: results from a phase 2 dose-ranging study
Ken Takeuchi, Hiroshi Nakase, Tadakazu Hisamatsu, et al.
Intestinal Research
|
November 18, 2025
The role of the Mediterranean diet in the management of inflammatory bowel disease: a narrative review
Peter Vivian Acire, Stephanie C Brown, Andrew S Day
Intestinal Research
|
November 6, 2025
Elderly-onset inflammatory bowel disease in Asia: clinical characteristics and therapeutic strategies
Jiyoung Yoon, Daein Kim, You Sun Kim
Intestinal Research
|
August 11, 2025
Peroxisome proliferator-activated receptors in inflammatory bowel disease: linking immunometabolism, lipid signaling, and therapeutic potential
Kiandokht Bashiri, Mark C Mattar, Alireza Meighani, et al.
Intestinal Research
|
February 18, 2016
Current status of biosimilars in the treatment of inflammatory bowel diseases
Dong Il Park
Page
of 84